{"product_id":"2023-ireland-blood-typing-grouping-and-infectious-disease-nat-screening-market-2022-supplier-shares-and-strategies-2022-2027-volume-and-sales-segment-forecasts-for-over-40-individual-immunohematology-and-nat-assays","title":"2023 Ireland Blood Typing, Grouping and Infectious Disease NAT Screening Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays","description":"\u003cp\u003e2023 Ireland Blood Typing, Grouping and Infectious Disease NAT Screening Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays\u003c\/p\u003e\n\n\u003cp\u003eThis unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.\u003c\/p\u003e\n\n\u003cp\u003eThe database from LeadingMarketResearch.com provides the 2022 supplier shares and strategies, the 2022-2027 volume and sales forecasts for over 40 immunohematology and NAT assays, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:\u003c\/p\u003e\n\n\u003cp\u003eBlood Typing and Grouping Tests\u003c\/p\u003e\n\n\u003cp\u003eABO, Antibody Panels, Antibody Screening\/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)\u003c\/p\u003e\n\n\u003cp\u003eInfectious Disease Screening Tests\u003c\/p\u003e\n\n\u003cp\u003eAIDS (HIV NAT, HIV-1\/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT\/SGPT), HTLV-I\/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT\u003c\/p\u003e\n\n\u003cp\u003eThe companies analyzed in the report include:\u003c\/p\u003e\n\n\u003cp\u003eAbbott\u003cbr\u003e\nBeckman Coulter\/Danaher\u003cbr\u003e\nBecton Dickinson\u003cbr\u003e\nBiokit\u003cbr\u003e\nbioMerieux\u003cbr\u003e\nBio-Rad\u003cbr\u003e\nDiagast\u003cbr\u003e\nDiaSorin\u003cbr\u003e\nFujirebio\u003cbr\u003e\nGrifols\u003cbr\u003e\nHologic\u003cbr\u003e\nImmucor\u003cbr\u003e\nLabCorp\u003cbr\u003e\nProteome Sciences\u003cbr\u003e\nQuest Diagnostics \u003cbr\u003e\nQuidelOrtho\u003cbr\u003e\nRoche\u003cbr\u003e\nSiemens Healthineers\u003cbr\u003e\nTecan\u003cbr\u003e\nThermo Fisher\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ - \/ MCW16234592","offer_id":47650974957874,"sku":null,"price":1020.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/2023-ireland-blood-typing-grouping-and-infectious-disease-nat-screening-market-2022-supplier-shares-and-strategies-2022-2027-volume-and-sales-segment-forecasts-for-over-40-individual-immunohematology-and-nat-assays","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}